Loading...
PDS Biotechnology Corporation
PDSB•NASDAQ
Healthcare
Biotechnology
$1.10
$-0.04(-3.51%)
PDS Biotechnology Corporation (PDSB) Financial Performance & Income Statement Overview
Review PDS Biotechnology Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-84279.13%
↓ 84279.13%
Net Income Growth
-91531.83%
↓ 91531.83%
Operating Cash Flow Growth
-4.14%
↓ 4.14%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-150.59%
↓ 150.59%
ROIC
-122.83%
↓ 122.83%
PDS Biotechnology Corporation (PDSB) Income Statement & Financial Overview
Review PDS Biotechnology Corporation's (PDSB) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $15128.00 | $14405.00 |
| Gross Profit | $0.00 | $0.00 | -$15128.00 | -$14405.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $4.53M | $6.80M | $4.53M | $6.70M |
| SG&A Expenses | $2.83M | $3.37M | $4.16M | $3.38M |
| Operating Expenses | $7.36M | $10.18M | $8.68M | $10.08M |
| Total Costs & Expenses | $7.36M | $10.18M | $8.68M | $10.10M |
| Interest Income | $503942.00 | $666770.00 | $675209.00 | $668895.00 |
| Interest Expense | $1.10M | $1.21M | $1.19M | $1.17M |
| Depreciation & Amortization | $15127.00 | $15131.00 | $15128.00 | $14405.00 |
| EBITDA | -$6.84M | -$9.50M | -$7.99M | -$9.41M |
| EBITDA Ratio | ||||
| Operating Income | -$7.36M | -$10.18M | -$8.68M | -$10.10M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$591782.00 | -$547964.00 | -$512762.00 | -$505850.00 |
| Income Before Tax | -$7.95M | -$10.73M | -$9.20M | -$10.60M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | -$869169.00 | $5.00 |
| Net Income | -$7.95M | -$10.73M | -$8.33M | -$10.60M |
| Net Income Ratio | ||||
| EPS | -$0.22 | -$0.29 | -$0.23 | -$0.30 |
| Diluted EPS | -$0.22 | -$0.29 | -$0.23 | -$0.30 |
| Weighted Avg Shares Outstanding | $37.80M | $36.81M | $36.69M | $34.82M |
| Weighted Avg Shares Outstanding (Diluted) | $37.80M | $36.81M | $36.69M | $34.82M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan